ASG is accelerating its doctor-led mission to enhance the quality of care, deliver eye care for all, and improve quality of life across India.
The core of “LANXESS Biosecurity Solutions” is a portfolio of scientifically formulated, highly effective and versatile biocidal products
The Group will continue to make proactive investments of its management resources in the life science business
Ketorolac Tromethamine is advised for the short-term management of moderately severe acute pain in adult patients
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
The participants discussed the latest developments under ABDM that shall enable true interoperability in the health sector and how effective adoption of ABDM can pave the way towards Universal Health Coverage
The voluntary program is the first time the FDA will allow excipient manufacturers to obtain review of certain novel excipients prior to their use in drug formulations.
Pluvicto and Scemblix launches are progressing well and we are awaiting data in earlier lines of therapy.
The newest facility has all the core specialties like Obstetrics and Gynaecology, Orthopaedics, Neurology, Cardiology, Paediatrics, General Surgery, and Urology
Subscribe To Our Newsletter & Stay Updated
